Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, National, Unicentric, Comparative, Double-Blind, Randomized, Non- Inferiority Clinical Trial to Evaluate the Efficacy and Safety of DNN.22.17.036 Compared to 10573048700 in the Treatment of Androgenetic Alopecia

NCT06355856 is registered in ClinicalTrials.gov with Ache Laboratorios Farmaceuticos S.A. as lead sponsor.

NCT NCT06355856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, National, Unicentric, Comparative, Double-Blind, Randomized, Non- Inferiority Clinical Trial to Evaluate the Efficacy and Safety of DNN.22.17.036 Compared to 10573048700 in the Treatment of Androgenetic Alopecia
Lead sponsor
Ache Laboratorios Farmaceuticos S.A.
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2024
Completion date
May 31, 2025
Enrollment
196 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia